Nuclera and Cytiva collaborate to accelerate characterization of proteins for drug development

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ System, has announced a collaboration with Cytiva, a global life sciences leader.

Continue ReadingNuclera and Cytiva collaborate to accelerate characterization of proteins for drug development

Researchers develop bioactive peptide with therapeutic and regenerative potential

Since the COVID-19 pandemic, global interest in antiviral therapies has increased significantly. Recently, with the growing attention to peptide-based drugs such as Wegovy, demand for effective peptide therapeutics derived from…

Continue ReadingResearchers develop bioactive peptide with therapeutic and regenerative potential

Fact: You could be inhaling nearly 70,000 plastic particles annually, here’s what it means for your health

Airborne microplastics and nanoplastics are increasingly detected in urban environments, with evidence linking inhalation exposure to inflammation, cardiovascular risks, and other health concerns. Researchers highlight urgent needs for improved detection,…

Continue ReadingFact: You could be inhaling nearly 70,000 plastic particles annually, here’s what it means for your health